A case of disseminated strongyloidiasis after multiple courses of immunosuppression

CMAJ. 2022 Jan 24;194(3):E89-E92. doi: 10.1503/cmaj.211056.

Authors

Jordan Mah¹, Anthony Lieu², Emma Holmes², Stephen Vaughan²

Affiliations

¹ Division of Infectious Diseases, Department of Medicine (Mah, Lieu, Vaughan); Department of Pathology and Laboratory Medicine (Holmes), University of Calgary, Calgary, Alta. [email protected].
² Division of Infectious Diseases, Department of Medicine (Mah, Lieu, Vaughan); Department of Pathology and Laboratory Medicine (Holmes), University of Calgary, Calgary, Alta.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antinematodal Agents / therapeutic use
Fatal Outcome
Humans
Immunocompromised Host*
Immunoglobulin G4-Related Disease / complications
Immunoglobulin G4-Related Disease / drug therapy*
Immunoglobulin G4-Related Disease / immunology
Immunosuppressive Agents / adverse effects*
Ivermectin / therapeutic use
Male
Risk Factors
Strongyloidiasis / diagnosis*
Strongyloidiasis / immunology*
Strongyloidiasis / prevention & control
Superinfection / diagnosis
Superinfection / immunology

Substances

Antinematodal Agents
Immunosuppressive Agents
Ivermectin